Bone Growth Stimulators Market Worth USD 1.41 Billion in 2022 Bone Growth Stimulator Market

Bone Growth Stimulator Market by Product (Device, Bone
Morphogenetic Protein, PRP), Application (Spinal Fusion,
Delay Union & Non-union Bone Fracture, Oral-maxillofacial),
End User (Hospitals, Home Care, Academia, CROs) - Global
Forecasts to 2022
According to the new market research report "Bone Growth Stimulators Market by Product
(Device, Bone morphogenetic protein, PRP), Application (spinal fusion, Delayed Union & Non
Union Bone Fracture, Dental, Maxillofacial), End User (Hospitals, Home care, Academia, CROs)
- Global Forecasts to 2022" , published by MarketsandMarkets™, the report studies the bone
growth stimulators market over the forecast period of 2017 to 2022. The market is expected to
reach USD 1.41 billion by 2022 growing at a CAGR of 5.4%.
Don’t miss out on business opportunities in Bone Growth Stimulators Market.
On the basis of product, the global bone growth stimulators market is segmented into bone
growth stimulation devices, bone morphogenetic protein (BMPs), and platelet-rich plasma (PRP).
The bone growth stimulation devices segment accounted for the largest share of the market in
2016. This large share is attributed to the growing aging population, rising preference for non-
surgical treatment procedures, and growing prevalence of nonunion fractures. Additionally, the
rising incidence of obesity, smoking, and diabetes which delay or inhibit bone healing after
surgery or trauma are further driving the market growth.
Speak to our analyst and gain crucial industry insights that will help your business grow:
https://www.marketsandmarkets.com/speaktoanalyst.asp?id=82341383
On the basis of application, the global bone growth stimulators market is segmented into spinal
fusion surgeries, delayed union and nonunion bone fractures, oral and maxillofacial surgeries,
and other applications. The spinal fusion surgeries segment accounted for the largest share of
the market in 2016. The large share of this segment is attributed to the growing geriatric
population, rising number of spine procedures (and rate of spinal fusion failure), established
1